Tian Jidong, Wang Zhiyong, An Jie, Dong Lin
Orthopedics Department, Gansu Provincial Hospital of TCM, Lanzhou, China.
Repair and Reconstruction Orthopedics, Gansu Provincial Hospital of TCM, Lanzhou, China.
Ann Palliat Med. 2021 Jul;10(7):7894-7904. doi: 10.21037/apm-21-1381.
We performed a systematic review and meta-analysis to evaluate the therapeutic effects of arthroscopic debridement and proximal fibular osteotomy (AD & PFO) on medial tibial articular genu osteoarthritis (MTAGO), so as to provide a theoretical reference for clinical surgical analgesia for patients.
We searched and screened randomized controlled trials (RCTs) focusing on AD & PFO on MTAGO surgical analgesia published before December 31, 2020 in English databases including PubMed, Embase, Medline, Ovid, Springer, and Web of Science. The Cochrane Handbook for Systematic Reviews of Intervention 5.0.2 was adopted for bias risk assessment, and Review Manager 5.3 was used to conduct the meta-analysis.
Twelve eligible studies were included, involving 765 research subjects. The meta-analysis results indicated that, relative to control group, satisfaction was markedly increased [mean difference (MD) =3.10; 95% confidence interval (CI), (1.48 to 6.51); Z=3; P=0.003], adverse reactions were reduced [MD =0.33; 95% CI, (0.08 to 1.32); Z=1.56; P=0.12] the hospital special surgery (HSS) score was lower [MD =5.37; 95% CI, (3.18 to 7.55); Z=4.82; P<0.00001], the visual analogue scale (VAS) score decreased [MD =-1.68; 95% CI, (-2.22 to -1.13); Z=6.01; P<0.00001], and the Knee Society score (KSS) was reduced [MD =6.16; 95% CI, (3.85 to 8.47); Z=5.23; P<0.00001]. However, the difference in the femoro-tibial (FT) angle between the control and study groups was not statistically considerable [MD =0.14; 95% CI, (-6.22 to 6.49); Z=0.04; P=0.97].
The combined adoption of AD & PFO for MTAGO surgical analgesia can reduce the HSS, KSS, and VAS scores of patients. The postoperative analgesia effect is good, and effectively reduces pain and adverse reactions in patients. Thus, it is suitable for analgesia in MTAGO.
我们进行了一项系统评价和荟萃分析,以评估关节镜下清创术和近端腓骨截骨术(AD&PFO)对内侧胫骨关节膝骨关节炎(MTAGO)的治疗效果,为患者临床手术镇痛提供理论参考。
我们检索并筛选了2020年12月31日前发表在包括PubMed、Embase、Medline、Ovid、Springer和Web of Science在内的英文数据库中关于AD&PFO对MTAGO手术镇痛的随机对照试验(RCT)。采用Cochrane干预系统评价手册5.0.2进行偏倚风险评估,并使用Review Manager 5.3进行荟萃分析。
纳入12项符合条件的研究,涉及765名研究对象。荟萃分析结果表明,与对照组相比,满意度显著提高[平均差(MD)=3.10;95%置信区间(CI),(1.48至6.51);Z=3;P=0.003],不良反应减少[MD =0.33;95%CI,(0.08至1.32);Z=1.56;P=0.12],医院特殊外科(HSS)评分更低[MD =5.37;95%CI,(3.18至7.55);Z=4.82;P<0.00001],视觉模拟量表(VAS)评分降低[MD = -1.68;95%CI,(-2.22至-1.13);Z=6.01;P<0.00001],膝关节协会评分(KSS)降低[MD =6.16;95%CI,(3.85至8.47);Z=5.23;P<0.00001]。然而,对照组和研究组之间的股胫(FT)角差异无统计学意义[MD =0.14;95%CI,(-6.22至6.49);Z=0.04;P=0.97]。
AD&PFO联合用于MTAGO手术镇痛可降低患者的HSS、KSS和VAS评分。术后镇痛效果良好,有效减轻患者疼痛和不良反应。因此,它适用于MTAGO的镇痛。